BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1813790)

  • 1. Renal osteodystrophy in dialyzed children.
    Salusky IB; Goodman WG
    Miner Electrolyte Metab; 1991; 17(4):273-80. PubMed ID: 1813790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy.
    Goodman WG; Salusky IB
    Contrib Nephrol; 1991; 90():189-95. PubMed ID: 1959345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis.
    Salusky IB; Goodman WG
    Child Nephrol Urol; 1991; 11(3):165-8. PubMed ID: 1777895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.
    Salusky IB; Coburn JW; Brill J; Foley J; Slatopolsky E; Fine RN; Goodman WG
    Kidney Int; 1988 May; 33(5):975-82. PubMed ID: 3392886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
    Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
    Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].
    Fournier A; Aparicio M
    Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone biopsy results and serum bone turnover parameters in uremic children.
    Ziólkowska H; Pańiczyk-Tomaszewska M; Debiński A; Polowiec Z; Sawicki A; Sieniawska M
    Acta Paediatr; 2000 Jun; 89(6):666-71. PubMed ID: 10914959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral and aluminum concentrations in patients undergoing CAPD.
    Giangrande A; Costanini S; Ballanti P; Castiglioni A; Caligara F; Pisoni B; Giordano R; Vernillo I; Berni S; Bonucci E
    Adv Perit Dial; 1992; 8():351-5. PubMed ID: 1361821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low turnover bone disease is the more common form of bone disease in CAPD patients.
    Rodriguez-Perez JC; Plaza C; Torres A; Vega N; Anabitarte A; Fernandez A; Lorenzo V; Hortal L; Palop L
    Adv Perit Dial; 1992; 8():376-80. PubMed ID: 1361827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D therapy in CAPD: what is its role?
    Hutchison AJ; Gokal R
    Adv Perit Dial; 1993; 9():253-6. PubMed ID: 8105937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
    Salusky IB; Ramirez JA; Oppenheim W; Gales B; Segre GV; Goodman WG
    Kidney Int; 1994 Jan; 45(1):253-8. PubMed ID: 8127016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal osteodystrophy in CAPD.
    Hutchison AJ; Freemont AJ; Lumb GA; Gokal R
    Adv Perit Dial; 1991; 7():237-9. PubMed ID: 1680434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol.
    Juergensen PH; Finkelstein FO; Cooper K; Santacroce S; Kliger AS
    Adv Perit Dial; 1993; 9():257-9. PubMed ID: 8105938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of intermittent calcitriol therapy in pediatric patients with secondary hyperparathyroidism.
    Salusky IB; Goodman WG; Kuizon BD
    Perit Dial Int; 1999; 19 Suppl 2():S441-4. PubMed ID: 10406561
    [No Abstract]   [Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal pulse calcitriol in the treatment of secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
    Chan HW; Tsang WK; Chan CM; Fung SK; So SO; Tang HL; Tong MK; Lee KC; Chan AY
    Perit Dial Int; 1998; 18(2):177-82. PubMed ID: 9576366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of bone disorders in chronic renal failure and dialyzed patients.
    Tzamaloukas AH
    Med Clin North Am; 1990 Jul; 74(4):961-74. PubMed ID: 2195265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients.
    Juergensen P; Santacroce S; Mooraki A; Cooper K; Finkelstein FO; Kliger AS
    Adv Perit Dial; 1994; 10():259-60. PubMed ID: 7999840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.
    Salusky IB; Kuizon BD; Belin TR; Ramirez JA; Gales B; Segre GV; Goodman WG
    Kidney Int; 1998 Sep; 54(3):907-14. PubMed ID: 9734615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.